company background image
PCYN logo

Procyon OTCPK:PCYN Stock Report

Last Price

US$0.20

Market Cap

US$1.6m

7D

-33.4%

1Y

-5.4%

Updated

27 Mar, 2024

Data

Company Financials

PCYN Stock Overview

Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States.

PCYN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Procyon Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Procyon
Historical stock prices
Current Share PriceUS$0.20
52 Week HighUS$0.31
52 Week LowUS$0.15
Beta-0.27
1 Month Change-33.36%
3 Month Change16.82%
1 Year Change-5.43%
3 Year Change-66.90%
5 Year Change-20.89%
Change since IPO-86.76%

Recent News & Updates

Recent updates

Shareholder Returns

PCYNUS Medical EquipmentUS Market
7D-33.4%2.2%0.4%
1Y-5.4%13.3%28.8%

Return vs Industry: PCYN underperformed the US Medical Equipment industry which returned 12% over the past year.

Return vs Market: PCYN underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is PCYN's price volatile compared to industry and market?
PCYN volatility
PCYN Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: PCYN's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine PCYN's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
198718Justice Andersonhttps://procyoncorp.com

Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States. It provides advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions, as well as hand sanitizer under the AMERIGEL brand name. The company also offers Advantagen, a surgical collagen powder that promotes wound closure and reduces the potential for surgical site infection; and rolled gauze wound care kits.

Procyon Corporation Fundamentals Summary

How do Procyon's earnings and revenue compare to its market cap?
PCYN fundamental statistics
Market capUS$1.61m
Earnings (TTM)-US$314.47k
Revenue (TTM)US$4.70m

0.3x

P/S Ratio

-5.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PCYN income statement (TTM)
RevenueUS$4.70m
Cost of RevenueUS$1.05m
Gross ProfitUS$3.65m
Other ExpensesUS$3.96m
Earnings-US$314.47k

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.039
Gross Margin77.60%
Net Profit Margin-6.69%
Debt/Equity Ratio0%

How did PCYN perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.